Mimura Yoshihisa

ミムラヨシヒサ | Mimura Yoshihisa

Affiliation and department：

Research field (1)： Clinical pharmacy

Research keywords (7)：がん悪液質 , 泌尿器科がん , 消化管吸収 , transporter , pharmacokinetics , 医療薬学 , 薬学教育

Research theme for competitive and other funds (5)：

2024 - 2026 がん悪液質の病態の可視化と新規治療アルゴリズムの開発
2023 - 2026 Optimizing Therapeutic Indices of Antibiotics and Software Development for the Implementation of Dose Adjustment Based on Model-informed Precision Dosing
2023 - 2024 生体電気インピーダンス法による体成分分析を応用した尿路上皮がん患者の新規がん悪液質治療戦略の開発
2022 - 2024 尿路上皮がん患者に対するアナモレリンを用いた新たな支持療法の確立-がん悪液質バイオマーカーに着目した検討-
2020 - 2024 前立腺がんの新規骨転移予測法の開発-骨密度に着目した研究-

Papers (19)：

Moeko Iida, Yoshihiko Tasaki, Akiko Kato, Tomoya Yasujima, Hiroaki Yuasa, Yasuhiro Maeda, Yoshihisa Mimura, Kunihiro Odagiri, Yuka Kimura, Nanami Ito, et al. Refractory diarrhea in a patient with metastatic breast cancer with ABCB1 polymorphism: A case report. Current Problems in Cancer: Case Reports. 2025. 18. 100367-100367
Yoshihiko Tasaki, Shuzo Hamamoto, Shimpei Yamashita, Junya Furukawa, Kazutoshi Fujita, Ryotaro Tomida, Makito Miyake, Noriyuki Ito, Hideto Iwamoto, Yoshihisa Mimura, et al. Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort study. Frontiers in Immunology. 2025. 15
Yoshihisa Mimura, Tomoya Yasujima, Katsuhisa Inoue, Shogo Akino, Chitaka Namba, Hiroyuki Kusuhara, Yutaro Sekiguchi, Kinya Ohta, Takahiro Yamashiro, Hiroaki Yuasa. SLC35G1 is a highly chloride-sensitive transporter responsible for the basolateral membrane transport in intestinal citrate absorption. eLife. 2024. 13
Shuzo Hamamoto, Yoshihiko Tasaki, Toshiharu Morikawa, Taku Naiki, Toshiki Etani, Kazumi Taguchi, Shoichiro Iwatsuki, Rei Unno, Tomoki Takeda, Takashi Nagai, et al. Efficacy and Safety of Immuno-Oncology Plus Tyrosine Kinase Inhibitors as Late-Line Combination Therapy for Patients with Advanced Renal Cell Carcinoma. Journal of Clinical Medicine. 2024. 13. 12. 3365-3365
Yoshihiko Tasaki, Nanami Ito, Yoshihisa Mimura, Yosuke Sugiyama, Ryo Ogawa, Takaya Shimura, Motoki Nakamura, Daisuke Kawakita, Shuzo Hamamoto, Takehiro Uemura, et al. Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patients. Asia-Pacific journal of clinical oncology. 2024

ｍore...

MISC (25)：

三村佳久, 内木拓, 小田切州広, 惠谷俊紀, 権田将一, 清水伸彦, 青木マリア, 森川敏治, 冨田実里, 田崎慶彦, et al. 尿路上皮がん患者に対するアナモレリンの有効性と安全性多施設共同無作為化比較試験. 日本癌治療学会学術集会抄録集. 2024. 62回. O27-5
Yoshihiko Tasaki, Shuzo Hamamoto, Taku Naiki, Toshiki Etani, Shoichiro Iwatsuki, Rei Unno, Takashi Nagai, Yoshihisa Mimura, Yosuke Sugiyama, Yuji Hotta, et al. MP10-06 ELEVATED EOSINOPHILS BEFORE 2 COURSE TREATMENT MAY BE A UNIVERSAL BIOMARKER FOR IMMUNE-RELATED ADVERSE EVENTS INDUCED BY COMMON TO DIFFERENT IMMUNE CHECKPOINT INHIBITOR AND CANCER TYPES INCLUDING TO UROLOGICAL CANCER. Journal of Urology. 2024. 211. 5S
杉山洋介, 内木拓, 三村佳久, 田崎慶彦, 片岡智哉, 小田切州広, 飯田萌子, 木村優花, 伊藤菜浪, 権田将一, et al. オキシコドンの血中濃度の変化とがん性疼痛との関連性の検討. 日本癌治療学会学術集会抄録集. 2023. 61回. O58-5
永井隆, 内木拓, 杉山洋介, 惠谷俊紀, 清水伸彦, 三村佳久, 野田祐介, 阪野里花, 窪田裕樹, 濱本周造, et al. mGPSは転移性尿路上皮癌患者の治療効果と予後を予測するマーカーである. 日本癌治療学会学術集会抄録集. 2023. 61回. P2-4
伊藤菜浪, 三村佳久, 田崎慶彦, 杉山洋介, 飯田萌子, 小田切州広, 木村優花, 堀田祐志, 日比陽子. ニボルマブの異なる投与スケジュールにおけるirAE発症プロファイルの解析. 日本癌治療学会学術集会抄録集. 2023. 61回. P45-5

ｍore...

Education (2)：

2014 - 2018 Nagoya City University Graduate School of Pharmaceutical Sciences
2008 - 2014 Nagoya City University Medicin Medicin

Work history (5)：

2024/07 - 現在 Graduate School of Medical Sciences, Department of Clinical Pharmaceutices, Nagoya City University
2018/04 - 現在 Nagoya City University
2023/04 - 2024/06 Graduate school of medical sciences, Nagoya city university Deparment of Clinical Pharmaceutics
2018/09 - 2023/04 Nagoya City University Graduate School of Pharmaceutical Sciences
2018/03 - Nagoya City University Graduate School of Pharmaceutical Sciences

Committee career (1)：

2020/07 - 現在愛知県病院薬剤師会学術教育委員会

Awards (2)：

2024/10 - 日本病院薬剤師会東海ブロック・日本薬学会東海支部合同学術大会2024 ベストプレゼンテーション賞薬物治療を個別最適化する能力の習得を志向した薬学実務実習の学習方略の構築
2023/03 - 日本薬学会長井記念若手薬学研究者賞

Association Membership(s) (3)：

Japanese Society of Hospital Pharmacists , JAPANESE SOCIETY OF PHARMACEUTICAL HEALTH CARE AND SCIENCES , THE PHARMACEUTICAL SOCIETY OF JAPAN

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page